Shenzhen Efung Holding Co., Ltd. - Net Worth and Insider Trading

Shenzhen Efung Holding Co., Ltd. Net Worth

The estimated net worth of Shenzhen Efung Holding Co., Ltd. is at least $59 Million dollars as of 2025-06-06. Shenzhen Efung Holding Co., Ltd. is the 2201 Interest of corporation controlled by you of 3D Medicines Inc and owns about 13,817,381 shares of 3D Medicines Inc (HKSE:01244) stock worth over $59 Million. Details can be seen in Shenzhen Efung Holding Co., Ltd.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Shenzhen Efung Holding Co., Ltd. has not made any transactions after 2022-12-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Shenzhen Efung Holding Co., Ltd.

Shenzhen Efung Holding Co., Ltd. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Shenzhen Efung Holding Co., Ltd. owns 1 companies in total, including 3D Medicines Inc (HKSE:01244) .

Click here to see the complete history of Shenzhen Efung Holding Co., Ltd.’s form 4 insider trades.

Insider Ownership Summary of Shenzhen Efung Holding Co., Ltd.

Ticker	Company	Transaction Date	Type of Owner
HKSE:01244	3D Medicines Inc	2022-12-15	2201 Interest of corporation controlled by you

Shenzhen Efung Holding Co., Ltd. Latest Holdings Summary

Shenzhen Efung Holding Co., Ltd. currently owns a total of 1 stock. Shenzhen Efung Holding Co., Ltd. owns 13,817,381 shares of 3D Medicines Inc (HKSE:01244) as of December 15, 2022, with a value of $59 Million.

Latest Holdings of Shenzhen Efung Holding Co., Ltd.

Ticker	Company	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
HKSE:01244	3D Medicines Inc	2022-12-15	13,817,381	4.24	58,585,695

Holding Weightings of Shenzhen Efung Holding Co., Ltd.

Shenzhen Efung Holding Co., Ltd. Form 4 Trading Tracker

According to the SEC Form 4 filings, Shenzhen Efung Holding Co., Ltd. has made a total of 2 transactions in 3D Medicines Inc (HKSE:01244) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in 3D Medicines Inc is the sale of 13,817,381 shares on December 15, 2022, which brought Shenzhen Efung Holding Co., Ltd. around $0.

Insider Trading History of Shenzhen Efung Holding Co., Ltd.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Shenzhen Efung Holding Co., Ltd. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Shenzhen Efung Holding Co., Ltd. Ownership Network

Ownership Network List of Shenzhen Efung Holding Co., Ltd.

No Data

Ownership Network Relation of Shenzhen Efung Holding Co., Ltd.

Shenzhen Efung Holding Co., Ltd. Owned Company Details

What does 3D Medicines Inc do?

Who are the key executives at 3D Medicines Inc?

Shenzhen Efung Holding Co., Ltd. is the 2201 Interest of corporation controlled by you of 3D Medicines Inc. Other key executives at 3D Medicines Inc include 2101 Beneficial owner Gong Zhaolong , 2101 Beneficial owner Zhu Pai , and 2101 Beneficial owner Dragon Prosper Holdings Limited .

3D Medicines Inc (HKSE:01244) Insider Trades Summary

Over the past 18 months, Shenzhen Efung Holding Co., Ltd. made no insider transaction in 3D Medicines Inc (HKSE:01244). Other recent insider transactions involving 3D Medicines Inc (HKSE:01244) include a net purchase of 3,000 shares made by Zhu Pai , a net purchase of 65,000 shares made by Gong Zhaolong , and a net sale of 0 shares made by Gong Zhaolong .

In summary, during the past 3 months, insiders sold 0 shares of 3D Medicines Inc (HKSE:01244) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of 3D Medicines Inc (HKSE:01244) were sold and 68,000 shares were bought by its insiders, resulting in a net purchase of 68,000 shares.

3D Medicines Inc (HKSE:01244)'s detailed insider trading history can be found in Insider Trading Tracker table.

3D Medicines Inc Insider Transactions

No Available Data

Shenzhen Efung Holding Co., Ltd. Mailing Address

Above is the net worth, insider trading, and ownership report for Shenzhen Efung Holding Co., Ltd.. Currently GuruFocus does not have mailing address information for Shenzhen Efung Holding Co., Ltd..

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.